Biological drug leaders meet ­

Home > Business > Industry

print dictionary print

Biological drug leaders meet ­

테스트

From left, Tom Pike, CEO of Quintiles, a biopharmaceutical contract research organization; Julie Gerberding, executive vice president of MSD and former director of the U.S. Centers for Disease Control; Brian H. Gu, co-head of JP Morgan Chase & Co.’s Asia Pacific M&A, TMT and Healthcare; and Sohn Yeo-won, National Institute of Food and Drug Safety Evaluation.

The group held a press conference Monday at the Global Bio Conference at Seoul’s COEX exhibition center in southern Seoul. About 2,000 officials from the biopharmaceutical industry, including Celltrion CEO Kim Hyoung-ki, as well as scholars and government officials are attending the forum that ends Friday. [NEWSIS]




tags

More in Industry

Posco Holdings reports big miss with 50% profit drop in 2022

Kia reports increase in net profit for 2022, all-time high operating profit, sales

Samsung Biologics reports record profit and big earnings surprise

KT&G to invest 4 trillion won over five years

Banks to be open for an extra hour a day starting Jan. 30

Related Stories

Solution to forced labor issue won't please everybody

Government pushes for tougher regulations on oil refiners after bountiful year

Kim Joo-hyung rises to second place on FedExCup after top-10 at The American Express

Oh Hyeon-gyu move to Celtic expected soon

Korea to scrap foreign investor registration in 2023
Log in to Twitter or Facebook account to connect
with the Korea JoongAng Daily
help-image Social comment?
s
lock icon

To write comments, please log in to one of the accounts.

Standards Board Policy (0/250자)


What’s Popular Now